{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:57:54Z","timestamp":1787317074601,"version":"build-2736575974"},"reference-count":74,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1001\/jamasurg.2018.4598","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T16:31:57Z","timestamp":1544027517000},"page":"159","source":"Crossref","is-referenced-by-count":91,"title":["Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients"],"prefix":"10.1001","volume":"154","author":[{"given":"Elizabeth R.","family":"Boskey","sequence":"first","affiliation":[{"name":"Center for Gender Surgery, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir H.","family":"Taghinia","sequence":"additional","affiliation":[{"name":"Center for Gender Surgery, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Ganor","sequence":"additional","affiliation":[{"name":"Center for Gender Surgery, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"srv180009r1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2016.303578","article-title":"Transgender population size in the United States: a meta-regression of population-based probability samples.","volume":"107","author":"Meerwijk","year":"2017","journal-title":"Am J Public Health"},{"issue":"11","key":"srv180009r2","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline.","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"srv180009r3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/13697130902780846","article-title":"Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.","volume":"12","author":"Benshushan","year":"2009","journal-title":"Climacteric"},{"issue":"1","key":"srv180009r5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/trgh.2015.0008","article-title":"A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals.","volume":"1","author":"White Hughto","year":"2016","journal-title":"Transgend Health"},{"issue":"4","key":"srv180009r6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"srv180009r7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4158\/EP15950.OR","article-title":"Metabolic effects of hormone therapy in transgender patients.","volume":"22","author":"Fernandez","year":"2016","journal-title":"Endocr Pract"},{"issue":"3","key":"srv180009r8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones.","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"srv180009r9","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons.","volume":"9","author":"Wierckx","year":"2012","journal-title":"J Sex Med"},{"issue":"7","key":"srv180009r10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/and.2014.46.issue-7","article-title":"Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.","volume":"46","author":"Asscheman","year":"2014","journal-title":"Andrologia"},{"issue":"4","key":"srv180009r11","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","article-title":"Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy.","volume":"93","author":"Ott","year":"2010","journal-title":"Fertil Steril"},{"issue":"4","key":"srv180009r12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"srv180009r13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.","volume":"93","author":"Gooren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"srv180009r14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1530\/EJE-09-1091","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline: commentary from a European perspective.","volume":"162","author":"Meriggiola","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"srv180009r15","first-page":"79","article-title":"Effects of hormone replacement therapy on depressive and anxiety symptoms after oophorectomy.","volume":"12","author":"\u00d0okovic","year":"2015","journal-title":"Med Glas (Zenica)"},{"issue":"11","key":"srv180009r16","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1111\/jsm.13022","article-title":"Testicular functions and clinical characterization of patients with gender dysphoria (GD) undergoing sex reassignment surgery (SRS).","volume":"12","author":"Schneider","year":"2015","journal-title":"J Sex Med"},{"issue":"6","key":"srv180009r17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/003693308903400601","article-title":"Oral contraception and post-operative thromboembolism: an epidemiological review.","volume":"34","author":"Hutchison","year":"1989","journal-title":"Scott Med J"},{"issue":"10","key":"srv180009r18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/dtb.1999.371078","article-title":"Drugs in the peri-operative period: 3\u2014hormonal contraceptives and hormone replacement therapy.","volume":"37","author":"Hutchison","year":"1999","journal-title":"Drug Ther Bull"},{"issue":"4","key":"srv180009r19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0002-9610(00)00331-7","article-title":"Estrogen replacement therapy and the surgeon.","volume":"179","author":"Shackelford","year":"2000","journal-title":"Am J Surg"},{"issue":"7454","key":"srv180009r21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations.","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"6","key":"srv180009r22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.bjps.2011.11.053","article-title":"Female-to-male transgender chest reconstruction: a large consecutive, single-surgeon experience.","volume":"65","author":"Berry","year":"2012","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"5715","key":"srv180009r23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/bmj.3.5715.123","article-title":"Postoperative thromboembolism and the use of oral contraceptives.","volume":"3","author":"Vessey","year":"1970","journal-title":"BMJ"},{"issue":"5","key":"srv180009r24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2105\/AJPH.62.5.680","article-title":"Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection.","volume":"62","author":"Greene","year":"1972","journal-title":"Am J Public Health"},{"issue":"7958","key":"srv180009r25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(76)90296-8","article-title":"Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis.","volume":"1","author":"Sagar","year":"1976","journal-title":"Lancet"},{"issue":"3","key":"srv180009r26","first-page":"372","article-title":"Estrogens and postoperative thrombosis evaluated by the radioactive iodine method.","volume":"151","author":"Astedt","year":"1980","journal-title":"Surg Gynecol Obstet"},{"issue":"9","key":"srv180009r27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/000331978003100903","article-title":"Incidence of thrombosis after gynecologic surgery evaluated by an improved 125I-fibrinogen uptake test.","volume":"31","author":"Bernstein","year":"1980","journal-title":"Angiology"},{"issue":"5","key":"srv180009r28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0049-3848(84)90283-4","article-title":"Oral contraceptives and surgery: reduced antithrombin and antifactor Xa levels without postoperative venous thrombosis in low-risk patients.","volume":"35","author":"Gallus","year":"1984","journal-title":"Thromb Res"},{"issue":"6519","key":"srv180009r29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study.","volume":"292","author":"Vessey","year":"1986","journal-title":"BMJ (Clin Res Ed)"},{"issue":"1","key":"srv180009r30","first-page":"43","article-title":"Evaluation of the role of exogenous estrogen in postoperative progress after laser skin resurfacing.","volume":"29","author":"Batra","year":"2003","journal-title":"Dermatol Surg"},{"issue":"2","key":"srv180009r31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1160\/TH04-03-0165","article-title":"Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty.","volume":"92","author":"Hurbanek","year":"2004","journal-title":"Thromb Haemost"},{"issue":"5","key":"srv180009r32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","article-title":"Is progestin an independent risk factor for incident venous thromboembolism? a population-based case-control study.","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thromb Res"},{"issue":"6","key":"srv180009r33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/000313481107700638","article-title":"Assessing the use of venous thromboembolism risk assessment profiles in the trauma population: is it necessary?","volume":"77","author":"Acu\u00f1a","year":"2011","journal-title":"Am Surg"},{"issue":"6","key":"srv180009r34","first-page":"267","article-title":"Deep vein thrombosis and pulmonary embolism after spine surgery: incidence and patient risk factors.","volume":"42","author":"Schulte","year":"2013","journal-title":"Am J Orthop (Belle Mead NJ)"},{"issue":"3","key":"srv180009r35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/ALN.0000000000001757","article-title":"Association of testosterone replacement therapy and the incidence of a composite of postoperative in-hospital mortality and cardiovascular events in men undergoing noncardiac surgery.","volume":"127","author":"Argalious","year":"2017","journal-title":"Anesthesiology"},{"issue":"2","key":"srv180009r36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5152\/akd.","article-title":"Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.","volume":"10","author":"\u00d6zaydin","year":"2010","journal-title":"Anadolu Kardiyol Derg"},{"issue":"1","key":"srv180009r37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00392-014-0754-7","article-title":"Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study.","volume":"104","author":"Simopoulos","year":"2015","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"srv180009r38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.ajkd.2016.06.013","article-title":"The effect of spironolactone on acute kidney injury after cardiac surgery: a randomized, placebo-controlled trial.","volume":"69","author":"Barba-Navarro","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"srv180009r39","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.bjps.2017.05.046","article-title":"Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction.","volume":"70","author":"Billon","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"3","key":"srv180009r40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1076029613499819","article-title":"Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study.","volume":"20","author":"Glueck","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"srv180009r41","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.mayocp.2015.05.012","article-title":"Risk of venous thromboembolism in men receiving testosterone therapy.","volume":"90","author":"Baillargeon","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"srv180009r42","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: adverse effects of testosterone therapy in adult men, a systematic review and meta-analysis.","volume":"95","author":"Fern\u00e1ndez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Pt 1","key":"srv180009r43","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.juro.2015.10.134","article-title":"Association between use of exogenous testosterone therapy and risk of venous thrombotic events among exogenous testosterone treated and untreated men with hypogonadism.","volume":"195","author":"Li","year":"2016","journal-title":"J Urol"},{"issue":"3","key":"srv180009r44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.chest.2016.05.007","article-title":"Association between testosterone replacement therapy and the incidence of DVT and pulmonary embolism: a retrospective cohort study of the Veterans Administration database.","volume":"150","author":"Sharma","year":"2016","journal-title":"Chest"},{"issue":"6","key":"srv180009r45","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"srv180009r46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/13697139909038066","article-title":"Hormone replacement therapy and venous thromboembolism.","volume":"2","author":"Greer","year":"1999","journal-title":"Climacteric"},{"issue":"5","key":"srv180009r47","first-page":"395","article-title":"Hormone replacement therapy and risk for venous thromboembolism: what\u2019s new and how do these findings influence clinical practice?","volume":"12","author":"Douketis","year":"2005","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"srv180009r48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ajh.24593","article-title":"Thrombotic issues in transgender medicine: a review.","volume":"92","author":"Shatzel","year":"2017","journal-title":"Am J Hematol"},{"issue":"10","key":"srv180009r49","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/gme.0b013e3182175e5c","article-title":"Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? estradiol transdermal system versus oral estrogen-only hormone therapy.","volume":"18","author":"Lalibert\u00e9","year":"2011","journal-title":"Menopause"},{"key":"srv180009r50","doi-asserted-by":"publisher","first-page":"c2519","DOI":"10.1136\/bmj.c2519","article-title":"Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.","volume":"340","author":"Renoux","year":"2010","journal-title":"BMJ"},{"issue":"11","key":"srv180009r51","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/j.1538-7836.2012.04919.x","article-title":"Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.","volume":"10","author":"Sweetland","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"srv180009r52","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","article-title":"Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.","volume":"95","author":"Tepper","year":"2017","journal-title":"Contraception"},{"issue":"2","key":"srv180009r53","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/01.ju.0000165567.99142.1f","article-title":"Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism.","volume":"174","author":"Ockrim","year":"2005","journal-title":"J Urol"},{"issue":"5","key":"srv180009r54","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1097\/01.ju.0000061024.75334.40","article-title":"Transdermal estradiol therapy for advanced prostate cancer\u2014forward to the past?","volume":"169","author":"Ockrim","year":"2003","journal-title":"J Urol"},{"issue":"2","key":"srv180009r55","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1194\/jlr.M500276-JLR200","article-title":"Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer.","volume":"47","author":"Purnell","year":"2006","journal-title":"J Lipid Res"},{"issue":"3","key":"srv180009r56","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.fertnstert.2007.07.1298","article-title":"Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review.","volume":"90","author":"Hemelaar","year":"2008","journal-title":"Fertil Steril"},{"issue":"2","key":"srv180009r57","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1055\/s-0037-1614026","article-title":"Oral ethinyl estradiol, but not transdermal 17\u00df-estradiol, increases plasma C-reactive protein levels in men.","volume":"84","author":"Giltay","year":"2000","journal-title":"Thromb Haemost"},{"issue":"5","key":"srv180009r58","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1161\/01.ATV.20.5.1396","article-title":"Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis.","volume":"20","author":"Giltay","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"srv180009r59","first-page":"74","article-title":"The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.","volume":"17","author":"Stephenson","year":"2013","journal-title":"Int J Pharm Compd"},{"issue":"7","key":"srv180009r60","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens, the ESTHER study.","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"srv180009r61","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/gme.0b013e3181e102eb","article-title":"Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.","volume":"17","author":"Canonico","year":"2010","journal-title":"Menopause"},{"issue":"10-13","key":"srv180009r62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal.","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"issue":"24","key":"srv180009r63","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception.","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"srv180009r64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.contraception.2009.07.004","article-title":"Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"srv180009r65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"},{"issue":"13","key":"srv180009r66","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1002\/cncr.26623","article-title":"Androgen deprivation and thromboembolic events in men with prostate cancer.","volume":"118","author":"Ehdaie","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"srv180009r67","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/bju.13360","article-title":"Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy.","volume":"118","author":"O\u2019Farrell","year":"2016","journal-title":"BJU Int"},{"issue":"3","key":"srv180009r68","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/1008-682X.143313","article-title":"Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer.","volume":"17","author":"Teoh","year":"2015","journal-title":"Asian J Androl"},{"issue":"6771","key":"srv180009r69","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/bmj.302.6771.269","article-title":"Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.","volume":"302","author":"Robinson","year":"1991","journal-title":"BMJ"},{"issue":"11","key":"srv180009r70","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1161\/01.CIR.91.11.2742","article-title":"Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses.","volume":"91","author":"Ajayi","year":"1995","journal-title":"Circulation"},{"issue":"1157","key":"srv180009r71","first-page":"U26","article-title":"Peri-operative use of oestrogen containing medications and deep vein thrombosis\u2014a national survey.","volume":"115","author":"Ardern","year":"2002","journal-title":"N Z Med J"},{"issue":"5","key":"srv180009r72","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00266-008-9156-4","article-title":"Do cosmetic surgeons consider estrogen-containing drugs to be of significant risk in the development of thromboembolism?","volume":"32","author":"Johnson","year":"2008","journal-title":"Aesthetic Plast Surg"},{"issue":"2","key":"srv180009r73","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/PRS.0000000000000908","article-title":"Practical guidelines for venous thromboembolism chemoprophylaxis in elective plastic surgery.","volume":"135","author":"Iorio","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"srv180009r74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.asj.2006.02.001","article-title":"The need for venous thromboembolism (VTE) prophylaxis in plastic surgery.","volume":"26","author":"Young","year":"2006","journal-title":"Aesthet Surg J"},{"key":"srv180009r4","unstructured":"World Professional Association of Transgender Health. Standards of care for the health of transsexual, transgender, and gender nonconforming people, 7th version. https:\/\/www.wpath.org\/. Published 2011. Accessed October 26, 2018."},{"key":"srv180009r20","unstructured":"Centre for Evidence Based Medicine; OCEBM Levels of Evidence Working Group. Oxford 2011 levels of evidence. https:\/\/www.cebm.net\/2016\/05\/ocebm-levels-of-evidence\/. Published May 1, 2016. Accessed May 17, 2018."}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamasurgery\/article-pdf\/154\/2\/159\/17266800\/jamasurgery_boskey_2018_rv_180009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T21:07:42Z","timestamp":1694466462000},"score":1,"resource":{"primary":{"URL":"http:\/\/archsurg.jamanetwork.com\/article.aspx?doi=10.1001\/jamasurg.2018.4598"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2018.4598","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}